Harvard Update on Severe Asthma 2025
Gain cutting-edge insights into the assessment and management of severe asthma through this two-day, live, hybrid (in-person and online) course led by the multidisciplinary team from the Severe Asthma Program at Brigham and Women’s Hospital and the Mass General Brigham Asthma Center. The course will explore both pediatric and adult asthma, focusing on comprehensive evaluation, diagnosis, and modern treatment approaches. Day one will focus on the assessment of severe asthma and related comorbidities, while day two will cover treatment strategies, including novel and emerging therapies. Topics include immunology and genetics of severe asthma, aspirin-exacerbated respiratory disease, eosinophilic lung diseases (including allergic bronchopulmonary aspergillosis), occupational asthma, obesity-related asthma, and pediatric considerations. Additional sessions will discuss gastroesophageal reflux disease, upper airway obstruction, and sinusitis/nasal polyposis — featuring insights from gastroenterology, otolaryngology, and voice specialists. Participants will receive an in-depth review of current GINA and NAEPP Guidelines, the latest biologic therapies, and innovative treatment approaches. Interactive lectures, multidisciplinary case discussions, and live Q&A sessions will ensure participants leave with practical skills to manage complex asthma cases effectively.
* Date of Original Release: March 8–9, 2025
LEARNING OBJECTIVES Upon completion of this activity, participants will be able to: WHO SHOULD ATTEND
HARVARD SEVERE ASTHMA UPDATE 2025